sábado, 14 de novembro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 30, 2026

Progress on share buyback programme

View original at globenewswire.com
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €1.0 billion share buyback programme announced on 30 April 2026, in total 860,000 shares were repurchased during the week of 22 June up to and including 26 June 2026…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • In total 860,000 shares were repurchased during the week of 22 June up to and including 26 June 2026, at an average price of €27.65 for a total amount of €23,778,357.00.

    60% confidence

  • As of June 2025, in Sustainalytics' view, ING's management of ESG material risk is 'Strong' with an ESG risk rating of 18.0 (low risk).

    60% confidence

  • ING Bank's more than 60,000 employees offer retail and wholesale banking services to customers in over 100 countries.

    60% confidence

  • ING's ESG rating by MSCI has been upgraded from 'AA' to 'AAA' in October 2025.

    60% confidence

  • The total number of shares repurchased under this programme to date is 13,060,000 at an average price of €25.97 for a total consideration of €339,107,589.50, approximately 33.91% of the maximum total value of the share buyback programme.

    60% confidence

Data points we hold from this source

ING Group · average repurchase price weekly27.65 EUR
ING Group · buyback completion percent33.91 percent
ING Group · shares repurchased cumulative13060000 shares
ING Group · shares repurchased weekly860000 shares
ING Group · average repurchase price cumulative25.97 EUR
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Progress on share buyback programme — Source | Via News | pt.VIA.NEWS